On June 2, 2025, uniQure shared that they’re aligned with the FDA about moving forward with their HTT-lowering gene therapy, AMT‑130. If the next round of results from their ongoing trial continues to ...

Chase waved him (crew chief Alan Gustafson) over, (Chase) got him around the car, came over and gave him a hug,” said ...

New Zealand’s private health system offers those with means the ability to buy the services of a specialist rather than wait weeks or months to be seen in the public system — usually by the same ...